NBTXR3 Radiotherapy-Activated Functionalized Hafnium Oxide Nanoparticles Show Efficient Antitumor Effects Across a Large Panel of Human Cancer Models

PURPOSE: The side effects of radiotherapy induced on healthy tissue limit its use. To overcome this issue and fully exploit the potential of radiotherapy to treat cancers, the first-in-class radioenhancer NBTXR3 (functionalized hafnium oxide nanoparticles) has been designed to amplify the effects of...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Ping, Marill, Julie, Darmon, Audrey, Mohamed Anesary, Naeemunnisa, Lu, Bo, Paris, Sébastien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8052129/
https://www.ncbi.nlm.nih.gov/pubmed/33880022
http://dx.doi.org/10.2147/IJN.S301182

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8052129/
https://www.ncbi.nlm.nih.gov/pubmed/33880022
http://dx.doi.org/10.2147/IJN.S301182

Ejemplares similares